增强对发育和生殖毒性知识:一种新的AOP源于谷氨酸耗尽的AOP
Alun Myden1, Susanne A Stalford1, Adrian Fowkes1
1Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PS, United Kingdom.
Current research in toxicology
|October 9, 2023
概括
综合测试和评估方法 (IATA) 使用不良结果途径 (AOP) 取代动物试验. 这项研究通过识别和填补知识差距,改进化学品安全评估来增强发育和生殖毒性 (DART) AOP网络.
科学领域:
- 毒理学和化学安全评估
- 计算毒理学计算毒理学
- 监管科学 监管科学
背景情况:
- 建议采用综合测试和评估方法 (IATA) 来组织化学安全的新方法方法,旨在取代传统的动物试验.
- 不良结果路径 (AOP) 框架可以捕捉IATA中毒性评估的机制方面.
- 充分的AOP覆盖面对于开发适合目的的IATA至关重要.
研究的目的:
- 为了评估发展和生殖毒性 (DART) AOP网络的成熟度和覆盖范围,与新的毒性数据集相比.
- 在现有的DART AOP网络中识别知识差距.
- 通过开发新的AOP和整合它们来增强DART AOP网络.
主要方法:
- 从使用经合组织测试指南TG-421和TG-422的研究中编制了一个新的毒性数据集.
- 评估基于DART AOP网络的in silico模型,使用精选的数据集.
- 确定了知识缺口,并开发了一种新的男性生育毒性的AOP,由"与电爱好者发生氨酸反应"启动.
主要成果:
- 评估显示,DART AOP网络的覆盖范围存在知识差距.
- 开发了一种新的AOP,将谷氨的反应与男性生育毒性联系起来.
- 这个新的AOP为策划关键事件的结构性警报提供了机制的逻辑.
结论:
- 整合新的AOP和相关警报,改善了DART AOP网络对相关化学空间的覆盖范围.
- 扩大AOP覆盖范围提高了针对监管终点的强大IATA的发展和信心.
- 这项工作有助于推进化学安全的非动物试验策略.
相关概念视频
Toxic Reactions: Overview
997
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
997
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
235
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
235
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


